Related Experiment Video
Updated: Jun 25, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
No-match ORESTES explored as tumor markers.
Barbara P Mello1, Eduardo F Abrantes, César H Torres
1Hospital A. C. Camargo, Rua Prof. Antônio Prudente 211, São Paulo, SP, Brazil.
Nucleic Acids Research
|March 10, 2009
Summary
Researchers identified thousands of novel human transcripts and potential cancer markers using expressed sequence tags (ESTs) and microarray analysis. This study enhances understanding of the human transcriptome and provides candidates for cancer diagnostics.
Area of Science:
- Genomics
- Transcriptomics
- Bioinformatics
Background:
- The human genome is pervasively transcribed, but comprehensive transcriptome annotation remains incomplete.
- The Human Cancer Genome Project generated extensive expressed sequence tag (EST) data.
Purpose of the Study:
- To identify novel human transcripts and potential molecular markers for cancer using previously unannotated ESTs.
- To investigate differential gene expression across various normal and tumor tissues.
Main Methods:
- Utilized ORESTES (open reading frame EST sequences) methodology to generate 1.2 million ESTs.
- Constructed a cDNA microarray to hybridize against 12 different tissue types.
- Applied real-time PCR to validate differential expression of candidate markers.
Main Results:
- Identified 3421 transcribed regions not associated with annotated transcripts (83.3% of the platform).
- Detected 1007 differentially expressed sequences across tissues.
- Found that 28% of analyzed sequences may represent noncoding RNAs.
- Validated three potential tumor markers in prostate tissues via real-time PCR.
Conclusions:
- The human genome exhibits extensive transcription, including many unannotated regions.
- The study provides a list of novel transcribed sequences and potential noncoding RNA markers.
- Identified molecular marker candidates for various cancers, with potential applications in diagnostics.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

